These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The identity of the so-called pink spot in schizophrenia and Parkinson's disease. Heslinga FJ; van Tilburg W; Stam FC Psychiatr Neurol Neurochir; 1970; 73(3):157-64. PubMed ID: 5310324 [No Abstract] [Full Text] [Related]
13. Urinary excretion of 3,4-dimethoxyphenylethylamine in Parkinson's disease. Rinne UK; Sonninen V Nature; 1967 Nov; 216(5114):489. PubMed ID: 6057254 [No Abstract] [Full Text] [Related]
14. 3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia. Narasimhachari N Biol Psychiatry; 1979 Feb; 14(1):215-9. PubMed ID: 420902 [No Abstract] [Full Text] [Related]
15. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients]. Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918 [No Abstract] [Full Text] [Related]
16. [Heboid onset of the progressive forms of juvenile schizophrenia (clinical picture and prognosis based on late follow-up findings)]. Eliava VN Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(11):107-15. PubMed ID: 7180295 [No Abstract] [Full Text] [Related]
17. [Psychomimetic compounds in the urine of schizophrenics. I. Study of catechol derivatives: so-called Pink Spot and 3.4-dimethoxyphenylethylamine (DMPEA)]. Willmann PK; Bidziński A; Jakimow B; Puzyński S Psychiatr Pol; 1977; 11(2):143-9. PubMed ID: 887672 [No Abstract] [Full Text] [Related]
18. [Clinical study of schizophrenia]. Henry J Soins Psychiatr; 1981 Dec; (14):7-13. PubMed ID: 6917427 [No Abstract] [Full Text] [Related]